Abstract
Introduction The Quadruple Aim recognizes that caring for the healthcare employee is necessary to optimize patient outcomes and health system performance. Although previous research has assessed pharmacists’ workload, this study is the first to describe pharmacist occupational fatigue − a characteristic of excessive workload that inhibits workers’ abilities to function at normal capacity. The purpose of this study was to describe occupational fatigue in pharmacists using exploratory factor analysis (EFA) − assessing whether dimensional structures used to describe occupational fatigue in other health professions fit pharmacist perceptions.
Methods A model was created to conceptualize “fatigue” domains found in the literature. A priori, the two domains identified were physical fatigue (ex. physical discomfort), and mental fatigue (ex. trouble thinking clearly). These domains were operationalized and used to create a paper survey that was distributed to licensed pharmacists at a pharmacy conference. An EFA was conducted to identify the key domains underlying pharmacist perceptions of fatigue.
Results A total of 283 surveys were distributed and 115 were returned and usable. Respondents were primarily white, female, worked 9.52 hours-per-day on average, and mean age of 39-years-old. The EFA suggested a statistically significant two-factor model (χ^2 9.73, p=0.28; TLI 0.998, RMSEA 0.048), which included physical fatigue (α = 0.87) and mental fatigue (α = 0.82).
Discussion The EFA yielded a structure similar to what was anticipated from the literature with physical and mental fatigue dimensions. This is just the first step in promoting systematic interventions to prevent or cope with fatigue and prevent the downstream patient, pharmacist, and institutional outcomes. By addressing fatigue and caring for employees, health care systems can take steps to work toward the Quadruple Aim.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding was received
Author Declarations
All relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
Any clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.
Yes
Data Availability
Not applicable
